Generic Medicines Dominating Prescription Market in the UK

The total number of prescriptions written in the UK tolled at 887 Million in 2009, which was estimated to reach 940 Million at the end of 2010. One of the important aspects about the UK, which is not unique but quite unusual in Europe, is that it is an International Nonproprietary Name (INN) market, where medical students are trained according to the INN prescription guidelines. Moreover, INN prescribing happens during the patent term as doctors are trained to write by INN.

 

Hence, the UK has over 80% of prescriptions that are being written by INN irrespective of the patent status of the product. This is the largest single element that has led to the growth of the generics market. Consequently, generics were estimated to account for around 86% of the prescriptions in 2009, says our new research report “UK Generics Market Analysis”.

 

Our team of experts has segmented the generics market by value, by prescriptions, and by therapeutics. The therapeutics segments covered by us in the report are Cardiovascular, Endocrine & Metabolic Agents, Respiratory Agents, Analgesics, and Gastrointestinal. Detail overview of the statistics and the generic drugs, which dominates the prescription market have also been covered in the report. Most importantly, thorough description of the regulations prevailing the country’s generics market has also been included in the report.

 

“UK Generics Market Analysis” provides thorough research and rational analysis along with reliable statistics of the UK generics market. The report also provides extensive information on the traditional markets as well as on the emerging technologies. Besides, an insight of the trends prevailing in the UK generics market has been covered in the report. Analysis and statistics regarding market size, growth, share, and segmentation have been thoroughly studied in the report to present a comprehensive view of the UK generics market. The report has thoroughly examined current market trends; industrial developments, and competitive landscape to enable clients understand the market structure and its progress in coming years.

For more information visit: http://www.rncos.com/Report/IM313.htm